Allen Capital Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Allen Capital Group's AMGN Position: Q2 2026 in Review
Allen Capital Group reduced its Amgen (AMGN) stake by 3% in Q2 2026, selling an estimated $15.1K and leaving 1,428 shares worth $517K. The position accounts for 0.04% of the portfolio, ranked #200.
Allen Capital Group first reported a position in AMGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.2M in Q2 2024. 1,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Allen Capital Group held 1,428 shares of Amgen worth $517K as of Q2 2026.
- Allen Capital Group sold 44 Amgen shares in Q2 2026, an estimated $15.1K.
- Amgen made up 0.04% of Allen Capital Group's portfolio in Q2 2026, its #200 holding.
- Allen Capital Group first reported a position in Amgen in Q1 2021 and has held it in 21 quarters since.
- Allen Capital Group's Amgen position peaked at $3.2M in Q2 2024.
- 1,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Allen Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.